These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 31175469)

  • 1. Cardiotoxicity of Immune Checkpoint Inhibitors.
    Zhang L; Jones-O'Connor M; Awadalla M; Zlotoff DA; Thavendiranathan P; Groarke JD; Villani AC; Lyon AR; Neilan TG
    Curr Treat Options Cardiovasc Med; 2019 Jun; 21(7):32. PubMed ID: 31175469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of Immune Checkpoint Inhibitors.
    Patel RP; Parikh R; Gunturu KS; Tariq RZ; Dani SS; Ganatra S; Nohria A
    Curr Oncol Rep; 2021 May; 23(7):79. PubMed ID: 33937956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Checkpoint Inhibitor-Associated Myocarditis.
    Ganatra S; Neilan TG
    Oncologist; 2018 Aug; 23(8):879-886. PubMed ID: 29802219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.
    Nielsen DL; Juhl CB; Nielsen OH; Chen IM; Herrmann J
    JAMA Oncol; 2024 Oct; 10(10):1390-1399. PubMed ID: 39172480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicities associated with immune checkpoint inhibitors.
    Yang S; Asnani A
    Curr Probl Cancer; 2018 Jul; 42(4):422-432. PubMed ID: 30173878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity in cancer immune-checkpoint therapy: Mechanisms, clinical evidence, and management strategies.
    Sun JY; Qu Q; Lou YX; Hua Y; Sun GZ; Sun W; Kong XQ
    Int J Cardiol; 2021 Dec; 344():170-178. PubMed ID: 34563597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What the Cardiologist Needs to Know About Cancer Immunotherapies and Complications.
    Frayberg M; Yung A; Zubiri L; Zlotoff DA; Reynolds KL
    Curr Treat Options Oncol; 2021 May; 22(6):53. PubMed ID: 34037918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience.
    Xiao J; Li X; Wang X; Guan Y; Liu H; Liang J; Li Y; Wang B; Wang J
    Front Cardiovasc Med; 2023; 10():1093383. PubMed ID: 37089888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity.
    Zarifa A; Lopez-Mattei J; Palaskas NL; Iliescu C; Durand JB; Kim PY
    Adv Exp Med Biol; 2021; 1342():377-387. PubMed ID: 34972975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature.
    Agrawal N; Khunger A; Vachhani P; Colvin TA; Hattoum A; Spangenthal E; Curtis AB; Dy GK; Ernstoff MS; Puzanov I
    Case Rep Oncol; 2019; 12(1):260-276. PubMed ID: 31011325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity from immune checkpoint inhibitors.
    Michel L; Rassaf T; Totzeck M
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100420. PubMed ID: 31517036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac imaging techniques for the assessment of immune checkpoint inhibitor-induced cardiotoxicity and their potential clinical applications.
    Li Y; Liu PJ; Zhang ZL; Wang YN
    Am J Cancer Res; 2022; 12(8):3548-3560. PubMed ID: 36119829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do.
    Zito C; Manganaro R; Ciappina G; Spagnolo CC; Racanelli V; Santarpia M; Silvestris N; Carerj S
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management.
    Zhou YW; Zhu YJ; Wang MN; Xie Y; Chen CY; Zhang T; Xia F; Ding ZY; Liu JY
    Front Pharmacol; 2019; 10():1350. PubMed ID: 31849640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge.
    Frascaro F; Bianchi N; Sanguettoli F; Marchini F; Meossi S; Zanarelli L; Tonet E; Serenelli M; Guardigli G; Campo G; Calabrò L; Pavasini R
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Checkpoint Inhibitors and Cardiotoxicity: A Comparative Meta-Analysis of Observational Studies and Randomized Controlled Trials.
    Sharma A; Alexander G; Chu JH; Markopoulos A; Maloul G; Ayub MT; Fidler MJ; Okwuosa TM
    J Am Heart Assoc; 2024 May; 13(10):e032620. PubMed ID: 38761070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.
    Agostinetto E; Eiger D; Lambertini M; Ceppi M; Bruzzone M; Pondé N; Plummer C; Awada AH; Santoro A; Piccart-Gebhart M; de Azambuja E
    Eur J Cancer; 2021 May; 148():76-91. PubMed ID: 33740500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity danger in immunotherapy.
    Jagielska B; Ozdowska P; Gepner K; Kubala S; Siedlecki JA; Sarnowski TJ; Sarnowska E
    IUBMB Life; 2020 Jun; 72(6):1160-1167. PubMed ID: 32359132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system.
    Michel L; Totzeck M; Lehmann L; Finke D
    Herz; 2020 Nov; 45(7):645-651. PubMed ID: 32533218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure.
    Waliany S; Lee D; Witteles RM; Neal JW; Nguyen P; Davis MM; Salem JE; Wu SM; Moslehi JJ; Zhu H
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():113-134. PubMed ID: 32776859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.